Thomas W. Dubensky, Chief Scientific Officer at ADURO BIOTECH, INC. (ADRO), sold 15,000 shares at $26.15 ($396K) on 2016-01-04, disclosed to the SEC on 2016-01-06.
Scheduled sale ($396k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.15 | 11,229 | $294K | 74.2% |
| 2 | $27.02 | 3,771 | $102K | 25.8% |
| Total | $26.37 avg | 15,000 | $396K | 100% |
| Filing → |
| ADRO | SELL | 2017-07-06 | $567K | — | Filing → |
| ADRO | SELL | 2017-06-05 | $1.4M | — | Filing → |
| ADRO | SELL | 2017-05-15 | $57K | — | Filing → |